ATRO Q1 2026 Earnings EPS Beats Estimates by 282 Amid Stable Operations Curis Inc Q1 2026 Earnings Deep EPS Miss as PreRevenue Biotech Continues Development ENIC Q4 2025 Earnings EPS Beat Exceeds Expectations Amid Mixed Revenue Disclosures Viridian Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Thyroid Eye Disease Pipeline UZF Q1 2026 Earnings Strong EPS Beat Signals Operational Efficiency Diebold Nixdorf DBD Q1 2026 Earnings EPS Beat Drives Modest Stock Upside